Published in Arch Intern Med on October 08, 2012
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry. Eur J Heart Fail (2015) 2.03
The epidemiology of cardiovascular diseases in sub-Saharan Africa: the Global Burden of Diseases, Injuries and Risk Factors 2010 Study. Prog Cardiovasc Dis (2013) 1.77
Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities. Heart (2013) 1.68
Prevalence and prognostic implications of anaemia and iron deficiency in Tanzanian patients with heart failure. Heart (2014) 1.45
HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research. J Acquir Immune Defic Syndr (2014) 1.22
Noncommunicable diseases in developing countries: focus on research capacity building. JAMA Intern Med (2013) 1.07
Heart failure care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med (2014) 1.06
The spectrum of cardiac disease in the West Region of Cameroon: a hospital-based cross-sectional study. Int Arch Med (2013) 1.02
Heart failure in sub-Saharan Africa. Curr Cardiol Rev (2013) 0.94
Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis. Health Policy Plan (2015) 0.89
Determinants of hypertension in a young adult Ugandan population in epidemiological transition-the MEPI-CVD survey. BMC Public Health (2015) 0.88
Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study. Clin Res Cardiol (2015) 0.86
A snapshot of cardiovascular diseases in Africa in the new millennium. Cardiovasc J Afr (2013) 0.86
Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries. Am Heart J (2014) 0.84
Noncommunicable Diseases In East Africa: Assessing The Gaps In Care And Identifying Opportunities For Improvement. Health Aff (Millwood) (2015) 0.84
The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease. Curr Cardiovasc Risk Rep (2015) 0.82
Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries. JACC Heart Fail (2015) 0.82
Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF). Int J Cardiol (2016) 0.81
Comparison of Indian subcontinent and Middle East acute heart failure patients: Results from the Gulf Acute Heart Failure Registry. Indian Heart J (2015) 0.81
The effect of left ventricular remodelling on soluble ST2 in a cohort of hypertensive subjects. J Hum Hypertens (2014) 0.80
The Causes of HIV-Associated Cardiomyopathy: A Tale of Two Worlds. Biomed Res Int (2016) 0.79
The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.79
Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries. Circulation (2016) 0.78
Epidemiology and cost of heart failure in children. Cardiol Young (2015) 0.78
Spiritual issues of people living and dying with advanced heart failure in Kenya: a qualitative serial interview study. BMJ Glob Health (2016) 0.78
Rheumatic heart disease screening: Current concepts and challenges. Ann Pediatr Cardiol (2017) 0.78
Right Ventricular Systolic Dysfunction Is Common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa. PLoS One (2016) 0.78
A review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with hypertension. Am J Cardiovasc Drugs (2013) 0.77
Scarcity of atrial fibrillation in a traditional African population: a community-based study. BMC Cardiovasc Disord (2014) 0.77
Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review. BMJ Open (2014) 0.77
Descriptive epidemiology and short-term outcomes of heart failure hospitalisation in rural Haiti. Heart (2016) 0.76
Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol (2015) 0.76
Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies. Sci Rep (2016) 0.76
The Cape Town Clinical Decision Rule for Streptococcal Pharyngitis in Children. Pediatr Infect Dis J (2016) 0.75
Linkage to Primary Care and Survival After Hospital Discharge for HIV-Infected Adults in Tanzania: A Prospective Cohort Study. J Acquir Immune Defic Syndr (2016) 0.75
Cardiovascular disease in Africa: epidemiological profile and challenges. Nat Rev Cardiol (2017) 0.75
The Pan-African Society of Cardiology (PASCAR) in 2013 and beyond. Cardiovasc J Afr (2013) 0.75
Demographics, Clinical Characteristics, Management, and Outcomes of Acute Heart Failure Patients: Observations from the Oman Acute Heart Failure Registry. Oman Med J (2016) 0.75
Propensity of people of African descent towards hypertension-associated cardiovascular pathologies. Hypertens Res (2016) 0.75
Patterns of international collaboration in cardiovascular research in sub-Saharan Africa. Cardiovasc J Afr (2016) 0.75
The proposed role of plasma NT pro-brain natriuretic peptide in assessing cardiac remodelling in hypertensive African subjects. Cardiovasc J Afr (2015) 0.75
Echocardiographic pattern of rheumatic valvular disease in a contemporary sub-Saharan African pediatric population: an audit of a major cardiac ultrasound unit in Yaounde, Cameroon. BMC Pediatr (2016) 0.75
Hypertension as an emerging risk factor for acute heart failure in Africa: comment on "The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries". Arch Intern Med (2012) 0.75
Characteristics of acute heart failure hospitalizations in a general medical ward in Southwestern Uganda. Int J Cardiol (2014) 0.75
Atrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment options. Int J Gen Med (2015) 0.75
International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives. J Am Heart Assoc (2016) 0.75
Noncommunicable diseases in developing countries: focus on research capacity building--reply. JAMA Intern Med (2013) 0.75
Markers of Atherosclerosis, Clinical Characteristics, and Treatment Patterns in Heart Failure: A Case-Control Study of Middle-Aged Adult Heart Failure Patients in Rural Kenya. Glob Heart (2016) 0.75
Sudden cardiac death in Africa. Cardiovasc J Afr (2014) 0.75
Short-term outcomes after hospital discharge in patients admitted with heart failure in Abeokuta, Nigeria: data from the Abeokuta Heart Failure Registry. Cardiovasc J Afr (2014) 0.75
Prevalence of anaemia among patients with heart failure at the Brazzaville University Hospital. Cardiovasc J Afr (2015) 0.75
Nigerian Population Research on Environment, Gene and Health (NIPREGH) - objectives and protocol. J Biomed Res (2014) 0.75
Pediatric Heart Failure, Lagging, and Sagging of Care in Low Income Settings: A Hospital Based Review of Cases in Ethiopia. Cardiol Res Pract (2016) 0.75
Heart failure, post-hospital mortality and renal function in Tanzania: A prospective cohort study. Int J Cardiol (2017) 0.75
Undiagnosed and diagnosed diabetes mellitus among hospitalised acute heart failure patients in Botswana. SAGE Open Med (2017) 0.75
Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years' experience. Br J Haematol (2016) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med (2014) 6.65
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet (2012) 6.42
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell (2007) 5.85
Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation (2012) 5.33
Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation (2005) 4.21
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Current status and future prospects of epidemiology and public health training and research in the WHO African region. Int J Epidemiol (2012) 3.60
Achieving the health Millennium Development Goals for South Africa: challenges and priorities. Lancet (2009) 3.35
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Prophylactic balloon occlusion of the internal iliac arteries to treat abnormal placentation: a cautionary case. Am J Obstet Gynecol (2007) 3.04
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med (2010) 2.71
Beta-blockers for hypertension. Cochrane Database Syst Rev (2012) 2.67
Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol (2008) 2.51
Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet (2010) 2.39
Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J (2010) 2.34
The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J (2009) 2.28
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail (2011) 2.28
Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation (2008) 2.27
Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J (2008) 2.20
A cost-effective strategy for primary prevention of acute rheumatic fever and rheumatic heart disease in children with pharyngitis. S Afr Med J (2013) 2.01
Epidemiology and etiology of cardiomyopathy in Africa. Circulation (2005) 1.95
Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation (2015) 1.95
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol (2013) 1.89
Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa? Circulation (2009) 1.86
Heart failure in sub-saharan Africa: time for action. J Am Coll Cardiol (2007) 1.85
Standing at the crossroads between new and historically prevalent heart disease: effects of migration and socio-economic factors in the Heart of Soweto cohort study. Eur Heart J (2010) 1.82
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. Eur Heart J (2011) 1.81
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest (2013) 1.80
Pregnancy in women with heart disease in sub-Saharan Africa. Arch Cardiovasc Dis (2011) 1.80
Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol (2004) 1.77
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol (2013) 1.75
Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis. Am J Hum Genet (2013) 1.70
Predictors of outcome in 176 South African patients with peripartum cardiomyopathy. Heart (2012) 1.68
Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J (2009) 1.65
A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: a prospective clinical registry of 1515 de novo cases. Eur J Heart Fail (2013) 1.65
A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure. Eur Heart J (2013) 1.65
Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World J Cardiol (2012) 1.64
Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa--the Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme. S Afr Med J (2006) 1.59
Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2013) 1.59
Epidemiology of heart failure in sub-Saharan Africa. Expert Rev Cardiovasc Ther (2009) 1.59
Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol (2013) 1.59
International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial. Eur J Heart Fail (2014) 1.58
Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol (2013) 1.57
Beta-blockers for hypertension. Cochrane Database Syst Rev (2012) 1.56
Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF. Eur Heart J (2013) 1.55
Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis (2006) 1.54
Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction. Psychosom Med (2004) 1.52
The BILAG-2004 index is sensitive to change for assessment of SLE disease activity. Rheumatology (Oxford) (2009) 1.52
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Bipedicled flaps in posttraumatic lower-extremity reconstruction. J Plast Reconstr Aesthet Surg (2013) 1.51
Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial. Eur Heart J (2013) 1.50
Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res (2002) 1.50
Cardiovascular disease in sub-Saharan Africa. Circulation (2005) 1.50
Left ventricular diastolic function parameters in hypertensives. J Natl Med Assoc (2005) 1.50
Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study. Eur J Heart Fail (2010) 1.49
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord (2005) 1.46
N-terminal pro-brain natriuretic peptide--a promising biomarker for the diagnosis of left ventricular hypertrophy in hypertensive women. Arch Cardiovasc Dis (2008) 1.43
Hypertensive heart failure in Nigerian Africans: insights from the Abeokuta Heart Failure Registry. J Clin Hypertens (Greenwich) (2015) 1.43
The daily incidence of acute heart failure is correlated with low minimal night temperature: cold immersion pulmonary edema revisited? J Card Fail (2006) 1.42
Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study: cardiovascular topic. Cardiovasc J Afr (2013) 1.41
Rapid clinical assessment of patients with acute heart failure: first blood pressure and oxygen saturation--is that all we need? Cardiology (2009) 1.40
Motion-guided segmentation for cine DENSE MRI. Med Image Anal (2008) 1.40
Knee pain, knee osteoarthritis, and the risk of fracture. Arthritis Rheum (2006) 1.38
Relaxin: review of biology and potential role in treating heart failure. Curr Heart Fail Rep (2010) 1.33
Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa. Heart (2013) 1.30
A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study "Heart Awareness Days". Int J Cardiol (2008) 1.29
The 10 'Best Buys' to combat heart disease, diabetes and stroke in Africa. Heart (2013) 1.29
Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail (2008) 1.29